Ginkgo Bioworks Holdings Inc (NYSE:DNA)
$ 9.66 -0.56 (-5.48%) Market Cap: 587.43 Mil Enterprise Value: 367.95 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 37/100

Ginkgo Bioworks Holdings Inc at Goldman Sachs Healthcare Conference Transcript

Jun 12, 2023 / 11:40PM GMT
Release Date Price: $78 (+5.41%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

That's our queue. We'll get started. Well, thank you very much for joining us. I'm Matt Sykes, life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of introducing Anna Marie Wagner, Head of Strategy at Ginkgo Bioworks. And Anna Marie, thank you very much for joining us.

Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development

You're welcome. Thanks for having me.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe we'll just start off with sort of a brief overview of some of the key accomplishments sort of in the first half of this year and what you're sort of most excited for...

Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development

Yes. So I think one big theme that you've seen in Ginkgo really over the last year, but certainly, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot